Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PAQR9 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.007 |
mRNA | STX4 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.007 |
mRNA | TDGF1 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.008 |
mRNA | NBPF26 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.008 |
mRNA | ASB9 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
mRNA | RHOJ | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
mRNA | MAP1S | CTRPv2 | pan-cancer | AAC | 0.095 | 0.008 |
mRNA | CCDC69 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
mRNA | ZBTB3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
mRNA | U2SURP | CTRPv2 | pan-cancer | AAC | 0.092 | 0.008 |